Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution
Neostigmine has been traditionally used as the agent of choice to reverse Neuromuscular Blockade (NMB) after muscle paralysis during general anesthesia. However, the use of neostigmine has not been without untoward events. Sugammadex is a novel drug that selectively binds to aminosteroid nondepolari...
Saved in:
Main Authors: | Michael S. Green, Archana Gundigi Venkatesh, Ranjani Venkataramani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Anesthesiology |
Online Access: | http://dx.doi.org/10.1155/2017/8197035 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuromuscular monitoring and incidence of postoperative residual neuromuscular blockade: a prospective observational study
by: Alessandra Piersanti, et al.
Published: (2025-01-01) -
Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy
by: Kadir ARSLAN, et al.
Published: (2024-03-01) -
Current Trends in Neuromuscular Blockade, Management, and Monitoring amongst Singaporean Anaesthetists
by: Wendy H. Teoh, et al.
Published: (2016-01-01) -
Deep neuromuscular blockade during radiofrequency catheter ablation under general anesthesia reduces the prevalence of atrial fibrillation recurrence when compared to moderate neuromuscular blockade: A randomized controlled trial
by: Eun Jung Oh, et al.
Published: (2025-01-01) -
Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
by: Manzo Suzuki, et al.
Published: (2014-01-01)